Azelastine and olopatadine in the treatment of allergic rhinitis.

@article{Kaliner2009AzelastineAO,
  title={Azelastine and olopatadine in the treatment of allergic rhinitis.},
  author={Michael A. Kaliner},
  journal={Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology},
  year={2009},
  volume={103 5},
  pages={
          373-80
        }
}

• Michael A. Kaliner
• Published 2009 in
  Annals of allergy, asthma & immunology : official…
• DOI:10.1016/S1081-1206(10)60355-9

OBJECTIVE To review the literature supporting current recommendations for nasal antihistamines as first-line therapy for allergic rhinitis. DATA SOURCES Published articles in the peer-reviewed medical literature. STUDY SELECTION Clinical trials focusing on the efficacy, safety, and recommended uses of the currently approved nasal antihistamines in the United States: azelastine nasal spray, 0.1%, and olopatadine nasal spray, 0.6%. RESULTS Azelastine nasal spray, 0.1%, and olopatadine nasal… CONTINUE READING

Save to Library

Create Alert

Cite

View on PubMed